Monte Rosa Therapeutics

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Industries

Biotechnology, Education

Headquarters

Boston, United States

Stage

IPO

Employees

51-200

Links

Org chart

Markus Warmuth

CEO

Collapse

Jennifer Champoux

Chief People & Operations Officer

Owen Wallace

Chief Scientific Officer

Filip Janku

Chief Medical Officer

CFO

Chief Data Scientist

CTO

General Counsel

SVP, Chemical Sciences & Process Development

Jullian G. Jones

SVP, Head of Business Development

Vladislav Zarayskiy

Director, Automation & Screening

Teams

View all

Board of Directors

11 members

Leadership Team

7 members

CEO and Executive Team

5 members

Discover similar companies

Truvian

San Diego, United States · Series C

Instil Bio

Dallas, United States · IPO

Mission Bio

San Francisco, United States · Series C

Clear Labs

Menlo Park, United States · Series C

Kinnate Biopharma

San Diego, United States · IPO

TrialSpark

New York, United States · Series C

Omega Therapeutics

Cambridge, United States · Post IPO Equity

Zageno

Cambridge, United States · Series C

Vividion Therapeutics

San Diego, United States · Series C

insitro

South San Francisco, United States · Series C

Korro Bio

Cambridge, United States · Series B

Sonoma Biotherapeutics

South San Francisco, United States · Corporate Round

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.